Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

Clinical trial NCT01813019 · TERMINATED

Trial details

NCT number: NCT01813019
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Patient Diagnosed With OCD and Resistant to SSRI Treatment Failed SSRI Over 12 Weeks at Appropriate Doses

Start date: 2013-11-01
Primary completion: 2014-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.